ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Vera Therapeutics Inc

Vera Therapeutics Inc (VERA)

35,01
1,34
(3,98%)
Geschlossen 18 Juni 10:00PM
35,01
0,00
( 0,00% )
Vor Marktöffnung: 11:13AM

Vera Therapeutics Inc (VERA) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
35,01
( - )
Gebot
35,01
Fragen
35,80
Volumen
-
0,00 Tagesbereich 0,00
19,0663 52-Wochen-Bereich 56,05
Marktkapitalisierung
Handelsende
35,01
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 1.156.807
Ausgegebene Aktien
71.782.904
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-6,15
Gewinn pro Aktie (EPS)
-5,57
Erlöse (LTM)
-
Nettogewinn (LTM)
-368,95M

Über Vera Therapeutics Inc

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) a... Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Brisbane, United States
Gegründet
2026
Vera Therapeutics Inc is listed in the Healthcare sector of the NASDAQ with ticker VERA. The last closing price for Vera Therapeutics was US$35,01. Over the last year, Vera Therapeutics shares have traded in a share price range of US$ 19,0663 to US$ 56,05.

Vera Therapeutics currently has 71.782.904 shares in issue. The market capitalisation of Vera Therapeutics is US$2,51 billion. Vera Therapeutics has a price to earnings ratio (PE ratio) of -6.15.

Option-Flow Vera Therapeutics (VERA)

Gesamtfluss

Bullisch

Nettoprämie

90k

Calls / Puts

100,00%

Käuf. / Verkä.

0,00%

OTM / ITM

100,00%

Sweeps

0,00%

VERA Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
13.5711.354961832131.4435.731.05100026734.1373378CS
40.832.4283206553534.1837.2930.59107935333.46024013CS
12-4.45-11.277242777539.464730.59110841137.25527607CS
26-13.82-28.302273192748.8356.0530.59113513241.10447214CS
5213.8565.453686200421.1656.0519.0663134204133.38516577CS
15620.41139.79452054814.656.059.24103940231.78272422CS
26019.64127.78139232315.3756.055.271462329.13905669CS

VERA - Frequently Asked Questions (FAQ)

What is the current Vera Therapeutics Inc share price?
The current share price of Vera Therapeutics Inc is US$ 35,01
How many Vera Therapeutics Inc shares are in issue?
Vera Therapeutics Inc has 71.782.904 shares in issue
What is the market cap of Vera Therapeutics Inc?
The market capitalisation of Vera Therapeutics Inc is USD 2,51B
What is the 1 year trading range for Vera Therapeutics Inc share price?
Vera Therapeutics Inc has traded in the range of US$ 19,0663 to US$ 56,05 during the past year
What is the PE ratio of Vera Therapeutics Inc?
The price to earnings ratio of Vera Therapeutics Inc is -6,15
What is the registered address of Vera Therapeutics Inc?
The registered address for Vera Therapeutics Inc is 2000 Sierra Point Parkway, Brisbane, California, 94005
What is the Vera Therapeutics Inc website address?
The website address for Vera Therapeutics Inc is veratx.com
Which industry sector does Vera Therapeutics Inc operate in?
Vera Therapeutics Inc operates in the Biotechnology & Life Sciences sector

VERA Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen